Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia

Published:2021-11-02 Issue:2 Volume:63 Page:503-505
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

da Cunha-Bang Caspar¹,Kirkby Nikolai S.²,Friis-Hansen Lennart³⁴,Niemann Carsten U.¹⁴^ORCID

Affiliation:

1. Department of Hematology, Rigshospitalet, Copenhagen, Denmark

2. Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark

3. Department of Clinical Biochemistry, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark

4. Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark

Funder

Novo Nordisk Foundation

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1973673

Reference15 articles.

1. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

2. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

3. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories

4. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain

5. Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Dysfunction and Infection – Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs;Acta Haematologica;2023-07-27

2. Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients;Journal of Chemotherapy;2023-04-27

3. Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis;Blood Cancer Journal;2022-12-23

4. COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study;HemaSphere;2022-09-22

5. Patients with CLL have a lower risk of death from COVID-19 in the Omicron era;Blood;2022-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3